Mathiesen T, von Holst H, Askensten U, Collins P V
Department of Neurosurgery, Karolinska Institute, Stockholm, Sweden.
Br J Neurosurg. 1989;3(5):575-81. doi: 10.3109/02688698909002849.
The histopathology and clinical course of 15 benign (grade I) and nine anaplastic (grade II-III) meningiomas was reviewed and compared with the nuclear DNA distribution patterns of the tumour cells as determined by Feulgen staining with ensuing image and flow cytometry. In addition, eight haemangioblastomas were studied. One benign meningioma, three anaplastic meningiomas and two haemangioblastomas were aneuploid. The outcome could be well predicted from standard histopathological criteria and a critical evaluation of the extent of removal at operation. The determination of nuclear DNA contents did not add further information useful in the management of these meningioma patients. Histopathologically aggressive or frankly anaplastic tumours had a bad outcome. The clinical results underline the importance of aggressive treatment of anaplastic meningiomas.
回顾了15例良性(I级)和9例间变性(II - III级)脑膜瘤的组织病理学和临床病程,并与通过福尔根染色及随后的图像分析和流式细胞术测定的肿瘤细胞核DNA分布模式进行了比较。此外,还研究了8例血管母细胞瘤。1例良性脑膜瘤、3例间变性脑膜瘤和2例血管母细胞瘤为非整倍体。根据标准组织病理学标准以及对手术切除范围的严格评估,可以很好地预测结果。细胞核DNA含量的测定并未为这些脑膜瘤患者的管理提供更多有用信息。组织病理学上具有侵袭性或明显间变的肿瘤预后不良。临床结果强调了积极治疗间变性脑膜瘤的重要性。